Identification of small molecule inhibitors of p27Kip1ubiquitination by high-throughput screening
Author:
Affiliation:
1. Antibiotics Laboratory; RIKEN; Hirosawa Wako-shi Saitama Japan
2. School of Biological Sciences; Universiti Sains Malaysia; Penang Malaysia
3. Global Research Cluster; RIKEN; Hirosawa Wako-shi Saitama Japan
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.12246/fullpdf
Reference50 articles.
1. Inhibitors of mammalian G1 cyclin-dependent kinases;Sherr;Genes Dev,1995
2. CDK inhibitors: positive and negative regulators of G1-phase progression;Sherr;Genes Dev,1999
3. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy;Chu;Nat Rev Cancer,2008
4. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell-cycle arrest;Polyak;Genes Dev,1994
5. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells;Slingerland;Mol Cell Biol,1994
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies;Frontiers in Oncology;2024-03-15
2. Thioridazine reverses trastuzumab resistance in gastric cancer by inhibiting S-phase kinase associated protein 2-mediated aerobic glycolysis;World Journal of Gastroenterology;2023-12-07
3. Discovery of Novel 1,3-Diphenylpyrazine Derivatives as Potent S-Phase Kinase-Associated Protein 2 (Skp2) Inhibitors for the Treatment of Cancer;Journal of Medicinal Chemistry;2023-05-19
4. Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review;Frontiers in Pharmacology;2023-04-05
5. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies;Journal of Endocrinological Investigation;2022-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3